Sonoma Pharmaceuticals
SNOA
#10412
Rank
โ‚ฌ5.23 M
Marketcap
3,08ย โ‚ฌ
Share price
-3.95%
Change (1 day)
12.88%
Change (1 year)

EPS for Sonoma Pharmaceuticals (SNOA)

EPS in 2025 (TTM): -2,05ย โ‚ฌ

According to Sonoma Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -1,96ย โ‚ฌ. In 2018 the company made an earnings per share (EPS) of -335,01ย โ‚ฌ an increase over its 2017 EPS that were of -427,87ย โ‚ฌ.

EPS history for Sonoma Pharmaceuticals from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-2,05ย โ‚ฌ
2018-335,01ย โ‚ฌ-21.7%
2017-427,87ย โ‚ฌ-241.62%
2016302,12ย โ‚ฌ-170.36%
2015-429,41ย โ‚ฌ-354.55%
2014168,70ย โ‚ฌ-122.01%
2013-766,49ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-0,81ย โ‚ฌ-58.70%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-0,20ย โ‚ฌ-89.57%๐Ÿ‡บ๐Ÿ‡ธ USA